TFF PHARMACEUTICALS, INC.
Shelf-stable dry powder universal influenza vaccine formulated using thin-film freezing technology
- Sector
- Biotech
- Headquarters
- FORT WORTH, TX
- Founded
- 2018
- Latest Form D
- $1.2M offered, Apr 2024
- Total capital
- $49.1M
- Federal grants
- $865K
- 1 award · 2023
- Rank in peer group#32 of 502
- Private capital raised
- $48.2M
- 4 Form D · last Apr 2024
- 31 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 21 pending
Capital timeline
Latest events
- Offering registeredForm D · SEC · 4th filing$1.2M
- Federal grantHealth and Human S · Phase II · Development of a shelf-stable universal mucosal HA-vaccine for the prevention of influenza$865K
- Private capital raisedForm D · SEC · 3rd filing$25.9M
- Private capital raisedForm D · SEC · 2nd filing$8.2M
- Private capital raisedForm D · SEC · 1st filing$14.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grants#32 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- AARON S. FLETCHERDirectorNamed in SEC Form D filings
- BRANDI S. ROBERTSDirectorNamed in SEC Form D filings
- BRIAN S. WINDSORDirectorNamed in SEC Form D filings
- CATHERINE S. LEEDirectorNamed in SEC Form D filings
- GLENN S. MATTESExecutive Officer, DirectorNamed in SEC Form D filings
- HARLAN S. WEISMANExecutive Officer, DirectorNamed in SEC Form D filings
Show all 14 people
- KIRK S. COLEMANExecutive OfficerNamed in SEC Form D filings
- MALCOLM S. FAIRBAIRNDirectorNamed in SEC Form D filings
- MICHAEL S. PATANEDirectorNamed in SEC Form D filings
- RANDY S. THURMANDirectorNamed in SEC Form D filings
- ROBERT S. MILLS, JR.DirectorNamed in SEC Form D filings
- STEPHEN S. ROCAMBOLIDirectorNamed in SEC Form D filings
- THOMAS S. KINGDirectorNamed in SEC Form D filings
- ZAMANEH S. MIKHAKExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 21- PendingPharmaceutical Compositions For Delivery Of Remdesivir By InhalationUSPTOApplication 18005522
- PendingDried Particle Inhalation For Delivery Of CannabisUSPTOApplication 17906529
- PendingDelayed Release Niclosamide FormulationUSPTOApplication 17823635
Show all 21 patent records
- Pharmaceutical Compositions For Delivery Of Remdesivir By InhalationAug 24, 2023 · Application 18005522Pending
- Dried Particle Inhalation For Delivery Of CannabisApr 20, 2023 · Application 17906529Pending
- Delayed Release Niclosamide FormulationApr 13, 2023 · Application 17823635Pending
- Compositions Of Cannabinoids For Delivery By InhalationOct 27, 2022 · Application 17642295Pending
- Methods To Prepare Dry Powders Using Suspension Based Thin Film FreezingOct 6, 2022 · Application 17693062Pending
- Thin Film Freezing Methods And Compositions Formulated From Dispersed Active AgentsApplication 63393059Pending
- Once Daily Formulations Of TacrolimusApplication PCTUS2022028972Pending
- Methods To Prepare Dry Powders Using Suspension Based Thin Film FreezingApplication PCTUS2022020037Pending
- Compositions Comprising Voriconazole Inhalation Powder And Methods Of Manufacture And Use ThereofApplication 63291055Pending
- Delayed Release Niclosamide FormulationApplication 63239333Pending
- Pharmaceutical Compositions For Delivery Of Remdesivir By InhalationApplication PCTUS2021042010Pending
- Dried Particle Inhalation For Delivery Of CannabisApplication PCTUS2021022868Pending
- Compositions Of Cannabinoids For Delivery By InhalationApplication PCTUS2020051388Pending
- Pharmaceutical Compositions For Delivery Of Remdesivir By InhalationApplication 63053339Pending
- Dried Particle Inhalation For Delivery Of CannabisApplication 62991896Pending
- Compositions Of Cannabinoids For Delivery By InhalationApplication PCTUS2023074345Pending
- Compositions Of Cannabinoids For Delivery By InhalationApplication 62902095Pending
- Thin Film Freezing Methods And Compositions Formulated From Dispersed Active AgentsApplication PCTUS2023071128Pending
- Large Scale Synthesis Of Pharmaceutical And Biologic Formulations Using Thin Film FreezingApplication PCTUS2023064222Pending
- Compositions Comprising Voriconazole Inhalation Powder And Methods Of Manufacture And Use ThereofApplication PCTUS2022081746Pending
- Compositions Of Cannabinoids For Delivery By InhalationApplication 63407088Pending
Related companies, and why
- IMMUSOFT CORPSimilar federal contract value in Biotech · null in contracts
- DARE BIOSCIENCE, INC.Similar federal contract value in Biotech · null in contracts
- Ventus TherapeuticsSimilar federal contract value in Biotech · null in contracts
- ACURASTEM INCSimilar federal contract value in Biotech · null in contracts
- OPHIDION, INC.Similar federal contract value in Biotech · null in contracts
- WESTERN ONCOLYTICS, LTDSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .